Jun Lu

Corporate Officer/Principal at SHANDONG BOAN BIOTECHNOLOGY CO., LTD.

58 year

Health Technology

Consumer Services

Profile

Jun Lu is currently the SVP & Head-Bio Technology Engineering at Shandong Boan Biotechnology Co., Ltd.
Prior to this, he worked as an Associate Director at Momenta Pharmaceuticals, Inc. from 2013 to 2015 and as a Senior Manager-Process Development at Ipsen Bioscience, Inc. from 2006 to 2013.
Mr. Lu received his undergraduate degree from Peking University in 1988, his graduate degree from the University of Southern California in 1997, and his MBA from The University of Chicago in 2003.

Jun Lu active positions

Companies	Position	Start
SHANDONG BOAN BIOTECHNOLOGY CO., LTD.	Corporate Officer/Principal	09/03/2015

All active positions of Jun Lu

Former positions of Jun Lu

Companies	Position	End
MOMENTA PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/03/2015
Ipsen Bioscience, Inc. Ipsen Bioscience, Inc. BiotechnologyHealth Technology Part of Ipsen SA, Ipsen Bioscience, Inc. is a company that develops and wholesales drugs. The company is based in Cambridge, MA.	Corporate Officer/Principal	01/03/2013

See the detail of Jun Lu's experience

Training of Jun Lu

Peking University	Undergraduate Degree
University of Southern California	Graduate Degree
The University of Chicago	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jun Lu's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
SHANDONG BOAN BIOTECHNOLOGY CO., LTD.	Health Technology

Private companies	2
Ipsen Bioscience, Inc. Ipsen Bioscience, Inc. BiotechnologyHealth Technology Part of Ipsen SA, Ipsen Bioscience, Inc. is a company that develops and wholesales drugs. The company is based in Cambridge, MA.	Health Technology
Momenta Pharmaceuticals, Inc. Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA.	Health Technology